诺和诺德发布降糖药Amycretin临床试验的早期结果。Amycretin表现出改善血糖水平的迹象。Amycretin在研究中表现出减重24.3%的效果。

Core Insights - Novo Nordisk has released early results from clinical trials of its diabetes drug Amycretin, showing promising signs of improving blood sugar levels [1] - Amycretin demonstrated a weight loss effect of 24.3% in the study [1]